Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
American Journal of Clinical Oncology|June 1, 1987
Chemotherapy of advanced colorectal cancer. A randomized trial of sequential methotrexate and 5-fluorouracilJ Mackintosh, A Coates, C Swanson, et al.
AJNR. American Journal of Neuroradiology|January 23, 2010
StarClose vascular closure device: safety and efficacy of deployment and reaccess in a neurointerventional radiology serviceR A McTaggart, D Raghavan, R A Haas, et al.
Urological Research|January 1, 1988
Stability of lectin binding properties expressed by human bladder carcinoma cell lines passaged in vitro or in nude miceP J Russell, J Wotherspoon, M Jelbart, et al.
Urology|September 1, 1985
Whole bladder photodynamic therapy for transitional cell carcinoma of bladderU O Nseyo, T J Dougherty, D G Boyle, et al.
Cancer Genetics and Cytogenetics|January 15, 1986
Rearrangement of chromosome 3 in renal cell carcinomaM A Yoshida, K Ohyashiki, H Ochi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancerW M Stadler, T Kuzel, B Roth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intracellular glutathione and cytotoxicity of platinum complexesL Pendyala, P J Creaven, R Perez, et al.
International Journal of Cancer|June 15, 1981
Fibronectin from human germ-cell tumors resembles amniotic fluid fibronectinE Ruoslahti, H Jalanko, D E Comings, et al.
Pageof 17